Monocytosis at the time of diagnosis has a negative prognostic impact in myelodysplastic syndromes with less than 5% bone marrow blasts

por Kasprzak, A., Assadi, C., Nachtkamp, K., Rudelius, M., Haas, R., Giagounidis, A., Götze, K., Gattermann, N., Germing, U.
Publicado 2022

JAM-A as a prognostic factor and new therapeutic target in multiple myeloma

por Solimando, A G, Brandl, A, Mattenheimer, K, Graf, C, Ritz, M, Ruckdeschel, A, Stühmer, T, Mokhtari, Z, Rudelius, M, Dotterweich, J, Bittrich, M, Desantis, V, Ebert, R, Trerotoli, P, Frassanito, M A, Rosenwald, A, Vacca, A, Einsele, H, Jakob, F, Beilhack, A
Publicado 2018

Cancer of unknown primary (CUP) through the lens of precision oncology: a single institution perspective

por Weiss, L., Heinrich, K., Zhang, D., Dorman, K., Rühlmann, K., Hasselmann, K., Klauschen, F., Kumbrink, J., Jung, A., Rudelius, M., Mock, A., Ormanns, Steffen, Kunz, W. G., Roessler, D., Beyer, G., Corradini, S., Heinzerling, L., Haas, M., von Bergwelt-Baildon, M., Boeck, S., Heinemann, V., Westphalen, C. B.
Publicado 2023